Treatment performance and microbial community structure in an aerobic granular sludge sequencing batch reactor amended with diclofenac, erythromycin, and gemfibrozil

This study characterizes the effects of three commonly detected pharmaceuticals—diclofenac, erythromycin, and gemfibrozil—on aerobic granular sludge. Approximately 150 µg/L of each pharmaceutical was fed in the influent to a sequencing batch reactor for 80 days, and the performance of the test react...

Full description

Bibliographic Details
Main Authors: Kylie B. Bodle, Rebecca C. Mueller, Madeline R. Pernat, Catherine M. Kirkland
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Microbiomes
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/frmbi.2023.1242895/full
_version_ 1797676864226983936
author Kylie B. Bodle
Kylie B. Bodle
Rebecca C. Mueller
Rebecca C. Mueller
Madeline R. Pernat
Madeline R. Pernat
Catherine M. Kirkland
Catherine M. Kirkland
author_facet Kylie B. Bodle
Kylie B. Bodle
Rebecca C. Mueller
Rebecca C. Mueller
Madeline R. Pernat
Madeline R. Pernat
Catherine M. Kirkland
Catherine M. Kirkland
author_sort Kylie B. Bodle
collection DOAJ
description This study characterizes the effects of three commonly detected pharmaceuticals—diclofenac, erythromycin, and gemfibrozil—on aerobic granular sludge. Approximately 150 µg/L of each pharmaceutical was fed in the influent to a sequencing batch reactor for 80 days, and the performance of the test reactor was compared with that of a control reactor. Wastewater treatment efficacy in the test reactor dropped by approximately 30-40%, and ammonia oxidation was particularly inhibited. The relative abundance of active Rhodocyclaceae, Nitrosomonadaceae, and Nitrospiraceae families declined throughout exposure, likely explaining reductions in wastewater treatment performance. Pharmaceuticals were temporarily removed in the first 12 days of the test via both sorption and degradation; both removal processes declined sharply thereafter. This study demonstrates that aerobic granular sludge may successfully remove pharmaceuticals in the short term, but long-term tests are necessary to confirm if pharmaceutical removal is sustainable.
first_indexed 2024-03-11T22:36:36Z
format Article
id doaj.art-1da163e8de234eaaa8afb64ab7ec9f15
institution Directory Open Access Journal
issn 2813-4338
language English
last_indexed 2024-03-11T22:36:36Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiomes
spelling doaj.art-1da163e8de234eaaa8afb64ab7ec9f152023-09-22T12:48:01ZengFrontiers Media S.A.Frontiers in Microbiomes2813-43382023-09-01210.3389/frmbi.2023.12428951242895Treatment performance and microbial community structure in an aerobic granular sludge sequencing batch reactor amended with diclofenac, erythromycin, and gemfibrozilKylie B. Bodle0Kylie B. Bodle1Rebecca C. Mueller2Rebecca C. Mueller3Madeline R. Pernat4Madeline R. Pernat5Catherine M. Kirkland6Catherine M. Kirkland7Department of Civil Engineering, Montana State University, Bozeman, MT, United StatesCenter for Biofilm Engineering, Montana State University, Bozeman, MT, United StatesCenter for Biofilm Engineering, Montana State University, Bozeman, MT, United StatesUnited States Department of Agriculture (USDA) Agricultural Research Service, Western Regional Research Center, Albany, CA, United StatesDepartment of Civil Engineering, Montana State University, Bozeman, MT, United StatesCenter for Biofilm Engineering, Montana State University, Bozeman, MT, United StatesDepartment of Civil Engineering, Montana State University, Bozeman, MT, United StatesCenter for Biofilm Engineering, Montana State University, Bozeman, MT, United StatesThis study characterizes the effects of three commonly detected pharmaceuticals—diclofenac, erythromycin, and gemfibrozil—on aerobic granular sludge. Approximately 150 µg/L of each pharmaceutical was fed in the influent to a sequencing batch reactor for 80 days, and the performance of the test reactor was compared with that of a control reactor. Wastewater treatment efficacy in the test reactor dropped by approximately 30-40%, and ammonia oxidation was particularly inhibited. The relative abundance of active Rhodocyclaceae, Nitrosomonadaceae, and Nitrospiraceae families declined throughout exposure, likely explaining reductions in wastewater treatment performance. Pharmaceuticals were temporarily removed in the first 12 days of the test via both sorption and degradation; both removal processes declined sharply thereafter. This study demonstrates that aerobic granular sludge may successfully remove pharmaceuticals in the short term, but long-term tests are necessary to confirm if pharmaceutical removal is sustainable.https://www.frontiersin.org/articles/10.3389/frmbi.2023.1242895/fullaerobic granular sludgewastewater treatmentpharmaceuticals and personal care productsemerging contaminantsbiodegradationbioremediation
spellingShingle Kylie B. Bodle
Kylie B. Bodle
Rebecca C. Mueller
Rebecca C. Mueller
Madeline R. Pernat
Madeline R. Pernat
Catherine M. Kirkland
Catherine M. Kirkland
Treatment performance and microbial community structure in an aerobic granular sludge sequencing batch reactor amended with diclofenac, erythromycin, and gemfibrozil
Frontiers in Microbiomes
aerobic granular sludge
wastewater treatment
pharmaceuticals and personal care products
emerging contaminants
biodegradation
bioremediation
title Treatment performance and microbial community structure in an aerobic granular sludge sequencing batch reactor amended with diclofenac, erythromycin, and gemfibrozil
title_full Treatment performance and microbial community structure in an aerobic granular sludge sequencing batch reactor amended with diclofenac, erythromycin, and gemfibrozil
title_fullStr Treatment performance and microbial community structure in an aerobic granular sludge sequencing batch reactor amended with diclofenac, erythromycin, and gemfibrozil
title_full_unstemmed Treatment performance and microbial community structure in an aerobic granular sludge sequencing batch reactor amended with diclofenac, erythromycin, and gemfibrozil
title_short Treatment performance and microbial community structure in an aerobic granular sludge sequencing batch reactor amended with diclofenac, erythromycin, and gemfibrozil
title_sort treatment performance and microbial community structure in an aerobic granular sludge sequencing batch reactor amended with diclofenac erythromycin and gemfibrozil
topic aerobic granular sludge
wastewater treatment
pharmaceuticals and personal care products
emerging contaminants
biodegradation
bioremediation
url https://www.frontiersin.org/articles/10.3389/frmbi.2023.1242895/full
work_keys_str_mv AT kyliebbodle treatmentperformanceandmicrobialcommunitystructureinanaerobicgranularsludgesequencingbatchreactoramendedwithdiclofenacerythromycinandgemfibrozil
AT kyliebbodle treatmentperformanceandmicrobialcommunitystructureinanaerobicgranularsludgesequencingbatchreactoramendedwithdiclofenacerythromycinandgemfibrozil
AT rebeccacmueller treatmentperformanceandmicrobialcommunitystructureinanaerobicgranularsludgesequencingbatchreactoramendedwithdiclofenacerythromycinandgemfibrozil
AT rebeccacmueller treatmentperformanceandmicrobialcommunitystructureinanaerobicgranularsludgesequencingbatchreactoramendedwithdiclofenacerythromycinandgemfibrozil
AT madelinerpernat treatmentperformanceandmicrobialcommunitystructureinanaerobicgranularsludgesequencingbatchreactoramendedwithdiclofenacerythromycinandgemfibrozil
AT madelinerpernat treatmentperformanceandmicrobialcommunitystructureinanaerobicgranularsludgesequencingbatchreactoramendedwithdiclofenacerythromycinandgemfibrozil
AT catherinemkirkland treatmentperformanceandmicrobialcommunitystructureinanaerobicgranularsludgesequencingbatchreactoramendedwithdiclofenacerythromycinandgemfibrozil
AT catherinemkirkland treatmentperformanceandmicrobialcommunitystructureinanaerobicgranularsludgesequencingbatchreactoramendedwithdiclofenacerythromycinandgemfibrozil